BioSpace News Archive

The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held at 10:00 a.m. at the Company’s headquarters chaired by Hedi Ben Brahim, Chairman and CEO, to approve the Company’s financial statements for the year ended December 31, 2020 and to vote the other resolutions submitted to their approval.

CVS Health Corporation announced that Karen Lynch, Executive Vice President and Chief Executive Officer, will participate in a fireside chat with investors at the Goldman Sachs 42nd Annual Healthcare Conference on June 9, 2020, at approximately 10:30 am EST.

Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today that its application for Marketing Authorization (MA) for Endari® in the Kingdom of Saudi Arabia has been accepted by the Saudi Food and Drug Authority (SFDA)

Dr. Nagdev, Director of Emergency Ultrasound at Highland Hospital, has been a leading voice for point-of-care ultrasound use in emergency medicine

New analysis suggests the California variant is more transmissible than unmutated strains, but vaccines are effective against it

BeyondSpring Inc. (“BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that management is scheduled to present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 9:00 am ET and will be available for 1x1 meetings.

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that it is completing patient enrollment in the Phase 2b CONTROL study evaluating TMB-001,

The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is pleased to announce the appointment of three new members to its Board of Directors.

The Government of Canada is working with all partners to protect the health and safety of Canadians and to reduce the spread of COVID-19 and the variants of concern in Canada.

BiologyWorks™, a medical test developer with a mission to deliver fast and accurate molecular testing, launches its innovative and affordable BiologyWorks k™ test.